Institutional Sign In

Go

Chirana T. Injecta Group

Chirana T. Injecta Group's price/earnings (P/E) rose 6.96% yoy to 26.7 in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group stock traded at EUR 46.5 per share at the end 2019 translating into a market capitalization of USD 52.1 mil. ...

Chirana T. Injecta Group's net profit fell 6.51% yoy to EUR 1.74 mil in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group made a net profit of EUR 1.74 mil with revenues of EUR 42.9 mil in 2019, down by 6.51% and up ...

Chirana T. Injecta Group's Net Debt/EBITDA rose 29.9% yoy to 2.37 in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group's net debt stood at EUR 13.4 mil and accounted for 40.1% of equity at the end of 2019. The ratio is ...

Profit Statement 2017 2018 2019
Sales EUR mil 33.3 35.8 42.9
Gross Profit EUR mil 14.0 15.7 12.0
EBITDA EUR mil 6.12 6.12 5.67
EBIT EUR mil 2.61 2.43 2.53
Financing Cost EUR mil 0.402 0.193 0.315
Pre-Tax Profit EUR mil 2.24 2.41 2.22
Net Profit EUR mil 1.69 1.86 1.74
Dividends EUR mil ... 0 0
Balance Sheet 2017 2018 2019
Total Assets EUR mil 51.4 52.3 57.4
Non-Current Assets EUR mil 34.7 33.8 31.2
Current Assets EUR mil 16.7 18.4 26.3
Working Capital EUR mil 11.0 11.0 16.5
Shareholders' Equity EUR mil 29.9 31.7 33.5
Liabilities EUR mil 21.5 20.5 23.9
Total Debt EUR mil 14.2 12.3 14.6
Net Debt EUR mil 13.1 11.1 13.4
Ratios 2017 2018 2019
ROE % 5.72 6.04 5.33
ROCE % 3.64 4.10 3.76
Gross Margin % 42.0 43.9 28.0
EBITDA Margin % 18.4 17.1 13.2
EBIT Margin % 7.85 6.77 5.89
Net Margin % 5.07 5.19 4.05
Net Debt/EBITDA 2.14 1.82 2.37
Net Debt/Equity % 43.7 35.2 40.1
Cost of Financing % 2.79 1.46 2.35
Valuation 2017 2018 2019
Market Capitalisation USD mil 55.7 53.2 52.1
Enterprise Value (EV) USD mil 71.4 66.0 67.2
Number Of Shares mil 1.00 1.00 1.00
Share Price EUR 46.5 46.5 46.5
EV/EBITDA 10.4 9.20 10.5
EV/Sales 1.91 1.57 1.38
Price/Earnings (P/E) 27.6 25.0 26.7
Price/Book Value (P/BV) 1.55 1.47 1.39
Dividend Yield % ... 0 0

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
income statement                                  
Sales EUR mil           33.1 33.5 32.3 33.3 35.8              
Gross Profit EUR mil           17.6 15.4 12.6 14.0 15.7              
EBIT EUR mil           5.61 4.30 1.61 2.61 2.43              
Net Profit EUR mil           3.65 3.08 1.13 1.69 1.86              
                                     
ROE % ...         22.1 14.7 4.02 5.72 6.04              
EBIT Margin %           16.9 12.8 4.99 7.85 6.77              
Net Margin %           11.0 9.20 3.49 5.07 5.19              
Employees ... ... ... ... ... ... ... ... ... 434   ... ... ... ... ... ...
balance sheet                                  
Total Assets EUR mil           48.6 53.6 52.5 51.4 52.3              
Non-Current Assets EUR mil           28.0 35.3 35.8 34.7 33.8              
Current Assets EUR mil           20.6 18.3 16.7 16.7 18.4              
                                     
Shareholders' Equity EUR mil           14.9 27.0 29.1 29.9 31.7              
Liabilities EUR mil           33.7 26.6 23.4 21.5 20.5              
Non-Current Liabilities EUR mil           6.26 15.0 12.4 9.30 6.00              
Current Liabilities EUR mil           22.5 11.6 11.9 12.2 14.5              
                                     
Net Debt/EBITDA           0.991 2.07 2.72 2.14 1.82              
Net Debt/Equity %           57.5 58.7 47.9 43.7 35.2              
Cost of Financing % ...         10.2 4.35 2.49 2.79 1.46              
cash flow                                  
Total Cash From Operations EUR mil ...         4.65 9.23 3.42 3.75 3.27              
Total Cash From Investing EUR mil ...         -4.15 -1.25 -0.844 -1.43 -1.06              
Total Cash From Financing EUR mil ...         -1.90 -1.08 -2.82 -1.96 -2.20              
Net Change In Cash EUR mil ...         -1.41 6.90 -0.241 0.353 0.009              
valuation                                  
Market Capitalisation USD mil ... ... ... ... ... ... ... 49.1 55.7 53.2              
Enterprise Value (EV) USD mil ... ... ... ... ... ... ... 63.8 71.4 66.0              
Number Of Shares mil ... ... ... ... ... ... ... 1.00 1.00 1.00              
Share Price EUR ... ... ... ... ... ... ... 46.5 46.5 46.5              
Price/Earnings (P/E) ... ... ... ... ... ... ... 41.2 27.6 25.0              
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ... 10.00 8.95 8.37              
EV/EBITDA ... ... ... ... ... ... ... 11.6 10.4 9.20              
Price/Book Value (P/BV) ... ... ... ... ... ... ... 1.60 1.55 1.47              
Dividend Yield % ... ... ... ... ... ... ... ... ... 0              
income statement Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
income statement                                  
Sales EUR mil           33.1 33.5 32.3 33.3 35.8              
Cost of Goods & Services EUR mil           15.6 18.1 19.6 19.3 20.1              
Gross Profit EUR mil           17.6 15.4 12.6 14.0 15.7              
Staff Cost EUR mil           6.30 7.73 7.85 8.68 9.61              
Other Operating Cost (Income) EUR mil           2.64 0 -0.345 -0.838 -0.013              
EBITDA EUR mil           8.63 7.67 5.14 6.12 6.12              
Depreciation EUR mil           3.03 3.36 3.52 3.51 3.69              
EBIT EUR mil           5.61 4.30 1.61 2.61 2.43              
Net Financing Cost EUR mil           0.912 0.583 0.392 0.402 0.193              
Financing Cost EUR mil           0.912 0.583 0.392 0.402 0.193              
Extraordinary Cost EUR mil           0 -0.370 -0.258 -0.033 -0.178              
Pre-Tax Profit EUR mil           4.69 4.09 1.48 2.24 2.41              
Tax EUR mil           1.04 1.01 0.351 0.557 0.553              
Minorities EUR mil           0 0 0 0 0              
Net Profit EUR mil           3.65 3.08 1.13 1.69 1.86              
Net Profit Avail. to Common EUR mil           3.65 3.08 1.13 1.69 1.86              
Dividends EUR mil ... ... ... ... ... ... ... ... ... 0              
growth rates                                  
Total Revenue Growth % ...         11.0 1.07 -3.60 3.07 7.74              
Staff Cost Growth % ...         7.67 22.8 1.47 10.6 10.7              
EBITDA Growth % ...         -10.1 -11.2 -33.0 19.2 0              
EBIT Growth % ...         -18.5 -23.3 -62.5 0 ...              
Pre-Tax Profit Growth % ...         -31.4 -12.9 -63.9 51.8 7.49              
Net Profit Growth % ...         -32.3 -15.6 -63.4 49.7 10.2              
ratios                                  
ROE % ...         22.1 14.7 4.02 5.72 6.04              
ROA % ...         8.61 6.03 2.12 3.25 3.59              
ROCE % ...         12.1 7.84 2.38 3.64 4.10              
Gross Margin %           53.0 46.0 39.2 42.0 43.9              
EBITDA Margin %           26.1 22.9 15.9 18.4 17.1              
EBIT Margin %           16.9 12.8 4.99 7.85 6.77              
Net Margin %           11.0 9.20 3.49 5.07 5.19              
Payout Ratio % ... ... ... ... ... ... ... ... ... 0              
Cost of Financing % ...         10.2 4.35 2.49 2.79 1.46              
Net Debt/EBITDA           0.991 2.07 2.72 2.14 1.82              
balance sheet Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
balance sheet                                  
Cash & Cash Equivalents EUR mil           1.41 0.984 0.743 1.10 1.11              
Receivables EUR mil           12.2 9.37 6.69 7.23 7.32              
Inventories EUR mil           6.87 7.91 9.27 8.38 10.0              
Other ST Assets EUR mil           0.060 0 < 0.001 < -0.001 < -0.001              
Current Assets EUR mil           20.6 18.3 16.7 16.7 18.4              
Property, Plant & Equipment EUR mil           19.9 19.1 17.5 15.3 13.0              
LT Investments & Receivables EUR mil           8.15 1.32 3.44 4.38 5.80              
Intangible Assets EUR mil           0 14.9 14.9 15.0 15.0              
Goodwill EUR mil           0 14.8 14.8 14.8 14.8              
Non-Current Assets EUR mil           28.0 35.3 35.8 34.7 33.8              
Total Assets EUR mil           48.6 53.6 52.5 51.4 52.3              
                                     
Trade Payables EUR mil           16.4 4.69 4.84 4.64 6.27              
Short-Term Debt EUR mil           5.37 6.32 6.37 6.84 7.52              
Other ST Liabilities EUR mil           0.719 0.628 0.743 0.756 0.742              
Current Liabilities EUR mil           22.5 11.6 11.9 12.2 14.5              
Long-Term Debt EUR mil           4.60 10.5 8.33 7.32 4.73              
Other LT Liabilities EUR mil           1.67 4.47 4.10 1.98 1.27              
Non-Current Liabilities EUR mil           6.26 15.0 12.4 9.30 6.00              
Liabilities EUR mil           33.7 26.6 23.4 21.5 20.5              
Equity Before Minority Interest EUR mil           14.9 27.0 29.1 29.9 31.7              
Minority Interest EUR mil           0 0 0 0 0              
Equity EUR mil           14.9 27.0 29.1 29.9 31.7              
growth rates                                  
Total Asset Growth % ...         34.0 10.3 -2.07 -2.00 1.59              
Shareholders' Equity Growth % ...         -18.4 81.4 7.87 2.70 6.07              
Net Debt Growth % ...         65.1 85.2 -11.9 -6.32 -14.7              
Total Debt Growth % ...         24.6 68.8 -12.6 -3.60 -13.5              
ratios                                  
Total Debt EUR mil           9.96 16.8 14.7 14.2 12.3              
Net Debt EUR mil           8.55 15.8 14.0 13.1 11.1              
Working Capital EUR mil           2.70 12.6 11.1 11.0 11.0              
Capital Employed EUR mil           30.7 47.9 46.9 45.7 44.9              
Net Debt/Equity %           57.5 58.7 47.9 43.7 35.2              
Current Ratio           0.915 1.57 1.40 1.37 1.27              
Quick Ratio           0.607 0.890 0.622 0.681 0.579              
cash flow Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
cash flow                                  
Net Profit EUR mil           3.65 3.08 1.13 1.69 1.86              
Depreciation EUR mil           3.03 3.36 3.52 3.51 3.69              
Non-Cash Items EUR mil ...         -9.83 12.7 -2.69 -1.60 -2.21              
Change in Working Capital EUR mil ...         7.80 -9.88 1.46 0.156 -0.077              
Total Cash From Operations EUR mil ...         4.65 9.23 3.42 3.75 3.27              
                                     
Capital Expenditures EUR mil ...         -4.15 -1.35 -1.03 -1.87 -1.45              
Other Investing Activities EUR mil ...         0 0.102 0.190 0.432 0.391              
Total Cash From Investing EUR mil ...         -4.15 -1.25 -0.844 -1.43 -1.06              
                                     
Dividends Paid EUR mil ... ... ... ... ... ... ... ... ... ...              
Issuance Of Debt EUR mil ...         1.97 6.86 -2.13 -0.529 -1.91              
Total Cash From Financing EUR mil ...         -1.90 -1.08 -2.82 -1.96 -2.20              
Net Change In Cash EUR mil ...         -1.41 6.90 -0.241 0.353 0.009              
ratios                                  
Days Sales Outstanding days           135 102 75.7 79.4 74.5              
Days Sales Of Inventory days           161 160 172 158 181              
Days Payable Outstanding days           385 94.7 89.9 87.7 114              
Cash Conversion Cycle days           -88.8 167 158 150 142              
Cash Earnings EUR mil           6.68 6.45 4.65 5.20 5.55              
Free Cash Flow EUR mil ...         0.497 7.98 2.58 2.32 2.21              
Capital Expenditures (As % of Sales) % ...         12.5 4.02 3.20 5.61 4.04              
other ratios Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
                                   
Employees ... ... ... ... ... ... ... ... ... 434   ... ... ... ... ... ...
Cost Per Employee USD per month ... ... ... ... ... ... ... ... ... 2,161   ... ... ... ... ... ...
Cost Per Employee (Local Currency) EUR per month ... ... ... ... ... ... ... ... ... 1,845   ... ... ... ... ... ...
Staff Cost (As % of Sales) %           19.0 23.1 24.3 26.1 26.8              
Effective Tax Rate %           22.2 24.6 23.7 24.8 22.9              
Total Revenue Growth (5-year average) % ... ... ... ... ... 11.6 10.1 2.50 2.40 3.74              
Total Revenue Growth (10-year average) % ... ... ... ... ... ... ... ... ... ...              
valuation Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
                                   
Market Capitalisation USD mil ... ... ... ... ... ... ... 49.1 55.7 53.2              
Enterprise Value (EV) USD mil ... ... ... ... ... ... ... 63.8 71.4 66.0              
Number Of Shares mil ... ... ... ... ... ... ... 1.00 1.00 1.00              
Share Price EUR ... ... ... ... ... ... ... 46.5 46.5 46.5              
EV/EBITDA ... ... ... ... ... ... ... 11.6 10.4 9.20              
Price/Earnings (P/E) ... ... ... ... ... ... ... 41.2 27.6 25.0              
Price/Cash Earnings (P/CE) ... ... ... ... ... ... ... 10.00 8.95 8.37              
P/FCF ... ... ... ... ... ... ... 18.0 20.1 21.0              
Price/Book Value (P/BV) ... ... ... ... ... ... ... 1.60 1.55 1.47              
Dividend Yield % ... ... ... ... ... ... ... ... ... 0              
Free Cash Flow Yield % ... ... ... ... ... ... ... 5.63 4.67 4.87              
Earnings Per Share (EPS) EUR ... ... ... ... ... ... ... 1.13 1.69 1.86              
Cash Earnings Per Share EUR ... ... ... ... ... ... ... 4.65 5.20 5.55              
Free Cash Flow Per Share EUR ... ... ... ... ... ... ... 2.58 2.32 2.21              
Book Value Per Share EUR ... ... ... ... ... ... ... 29.1 29.9 31.7              
Dividend Per Share EUR ... ... ... ... ... ... ... ... ... 0              
EV/Sales ... ... ... ... ... ... ... 1.84 1.91 1.57              
EV/EBIT ... ... ... ... ... ... ... 36.9 24.3 23.2              
EV/Free Cash Flow ... ... ... ... ... ... ... 23.1 27.5 25.5              
EV/Capital Employed ... ... ... ... ... ... ... 1.29 1.30 1.28              
Earnings Per Share Growth % ... ... ... ... ... ... ... ... 49.7 10.2              
Cash Earnings Per Share Growth % ... ... ... ... ... ... ... ... 11.7 6.89              
Book Value Per Share Growth % ... ... ... ... ... ... ... ... 2.70 6.07              

Get all company financials in excel:

Download Sample   $19.99

Chirana T. Injecta Group's Capital Expenditures rose 73.8% yoy to EUR 0.379 mil in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group invested a total of EUR 0.379 mil in 2019, down 73.8% compared to the previous year. Historically, between 2010 - 2019, the company's investments stood at a high of EUR 4.15 mil in 2014 and a low of EUR 0.088 mil in ...

Chirana T. Injecta Group's Share Price remain unchanged yoy at EUR 46.5 in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group stock traded at EUR 46.5 per share at the end 2019 implying a market capitalization of USD 52.1 mil. Since the end of 2014, stock has appreciated by % implying an annual average growth of % In absolute terms, the value of the company ...

Chirana T. Injecta Group's Net Margin fell 21.9% yoy to 4.05% in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group made a net profit of EUR 1.74 mil with revenues of EUR 42.9 mil in 2019, down by 6.51% and up by 19.7%, respectively, compared to the previous year. This translates into a net margin of 4.05%. Historically, between 2009 and 2019...

Chirana T. Injecta Group's P/FCF rose 267% yoy to 77.1 in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group stock traded at EUR 46.5 per share at the end 2019 translating into a market capitalization of USD 52.1 mil. Since the end of 2014, the stock has appreciated by 0% representing an annual average growth of %. At the end of 2019, t...

Chirana T. Injecta Group's ROCE fell 8.51% yoy to 3.76% in 2019

By Helgi Analytics - March 16, 2021

Chirana T. Injecta Group made a net profit of EUR 1.74 mil in 2019, down 6.51% compared to the previous year. Historically, between 2009 and 2019, the company's net profit reached a high of EUR 6.09 mil in 2012 and a low of EUR 1.13 mil in 2016. The resul...

More News

Finance

Chirana T. Injecta Group has been growing its sales by 5.33% a year on average in the last 5 years. EBITDA has grown on average by 4.75% a year during that time to total of EUR 8.70 mil in 2025, or 18.1% of sales. That’s compared to 18.1% average margin seen in last five years.

The company netted EUR 4.14 mil in 2025 implying ROE of 9.33% and ROCE of 8.41%. Again, the average figures were 8.89% and 7.37%, respectively when looking at the previous 5 years.

Chirana T. Injecta Group’s net debt amounted to EUR 2.86 mil at the end of 2025, or 6.36% of equity. When compared to EBITDA, net debt was 0.329x, down when compared to average of 0.870x seen in the last 5 years.

Valuation

Chirana T. Injecta Group stock traded at EUR 46.5 per share at the end of 2025 resulting in a market capitalization of USD 52.1 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 5.61x and price to earnings (PE) of 11.2x as of 2025.

More Companies in Slovak Pharmaceutical Sector